{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:56:31Z","timestamp":1788965791819,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Alzheimer's Association (US) & Brain Canada","award":["AARG501466"],"award-info":[{"award-number":["AARG501466"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12975-018-0672-5","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T10:31:29Z","timestamp":1542277889000},"page":"522-533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment"],"prefix":"10.1007","volume":"10","author":[{"given":"Di","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hennebelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios J.","family":"Sahlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Masellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Cogo-Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pak Cheung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Pettersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald T.","family":"Stuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra E.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameer Y.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0030-8908","authenticated-orcid":false,"given":"Walter","family":"Swardfager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"672_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689\u2013701. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(10)70104-6\n                    \n                  .","journal-title":"Lancet Neurol"},{"key":"672_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483\u201397. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(13)70060-7\n                    \n                  .","journal-title":"Lancet Neurol"},{"key":"672_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001140","volume":"4","author":"JM Wardlaw","year":"2015","unstructured":"Wardlaw JM, Vald\u00e9s Hern\u00e1ndez MC, Mu\u00f1oz-Maniega S. What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc. 2015;4:001140. \n                    https:\/\/doi.org\/10.1161\/JAHA.114.001140\n                    \n                  .","journal-title":"J Am Heart Assoc"},{"key":"672_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neubiorev.2018.01.010","volume":"87","author":"W Swardfager","year":"2018","unstructured":"Swardfager W, Hennebelle M, Yu D, Hammock BD, Levitt AJ, Hashimoto K, et al. Metabolic\/inflammatory\/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target. Neurosci Biobehav Rev. 2018;87:56\u201366. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2018.01.010\n                    \n                  .","journal-title":"Neurosci Biobehav Rev"},{"key":"672_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3945\/an.114.007732","volume":"6","author":"M Gabbs","year":"2015","unstructured":"Gabbs M, Leng S, Devassy JG, Monirujjaman M, Aukema HM. Advances in our understanding of oxylipins derived from dietary PUFAs. Adv Nutr. 2015;6:513\u201340. \n                    https:\/\/doi.org\/10.3945\/an.114.007732\n                    \n                  .","journal-title":"Adv Nutr"},{"key":"672_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349\u201361. \n                    https:\/\/doi.org\/10.1038\/nri2294\n                    \n                  .","journal-title":"Nat Rev Immunol"},{"key":"672_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2017.05.004","volume":"179","author":"CM Davis","year":"2017","unstructured":"Davis CM, Liu X, Alkayed NJ. Cytochrome P450 eicosanoids in cerebrovascular function and disease. Pharmacol Ther. 2017;179:31\u201346. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2017.05.004\n                    \n                  .","journal-title":"Pharmacol Ther"},{"key":"672_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrn.2017.48","volume":"18","author":"K Kisler","year":"2017","unstructured":"Kisler K, Nelson AR, Montagne A, Zlokovic BV. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci. 2017;18:419\u201334. \n                    https:\/\/doi.org\/10.1038\/nrn.2017.48\n                    \n                  .","journal-title":"Nat Rev Neurosci"},{"key":"672_CR9","doi-asserted-by":"publisher","first-page":"7758","DOI":"10.1038\/s41598-017-08227-z","volume":"7","author":"Y Chen","year":"2017","unstructured":"Chen Y, Tian H, Yao E, Tian Y, Zhang H, Xu L, et al. Soluble epoxide hydrolase inhibition promotes white matter integrity and long-term functional recovery after chronic hypoperfusion in mice. Sci Rep. 2017;7:7758. \n                    https:\/\/doi.org\/10.1038\/s41598-017-08227-z\n                    \n                  .","journal-title":"Sci Rep"},{"key":"672_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature25013","volume":"552","author":"J Hu","year":"2017","unstructured":"Hu J, Dziumbla S, Lin J, Bibli S-I, Zukunft S, de Mos J, et al. Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy. Nature. 2017;552:248\u201352. \n                    https:\/\/doi.org\/10.1038\/nature25013\n                    \n                  .","journal-title":"Nature"},{"key":"672_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nm0597-562","volume":"3","author":"MF Moghaddam","year":"1997","unstructured":"Moghaddam MF, Grant DF, Cheek JM, Greene JF, Williamson KC, Hammock BD. Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase. Nat Med. 1997;3:562\u20136.","journal-title":"Nat Med"},{"key":"672_CR12","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1210\/endo.143.6.8834","volume":"143","author":"B Lecka-Czernik","year":"2002","unstructured":"Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology. 2002;143:2376\u201384. \n                    https:\/\/doi.org\/10.1210\/endo.143.6.8834\n                    \n                  .","journal-title":"Endocrinology"},{"key":"672_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1006\/abbi.2001.2434","volume":"392","author":"MF Sisemore","year":"2001","unstructured":"Sisemore MF, Zheng J, Yang JC, Thompson DA, Plopper CG, Cortopassi GA, et al. Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction. Arch Biochem Biophys. 2001;392:32\u20137. \n                    https:\/\/doi.org\/10.1006\/abbi.2001.2434\n                    \n                  .","journal-title":"Arch Biochem Biophys"},{"key":"672_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/07315724.2003.10719328","volume":"22","author":"S Viswanathan","year":"2003","unstructured":"Viswanathan S, Hammock BD, Newman JW, Meerarani P, Toborek M, Hennig B. Involvement of CYP 2C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells. J Am Coll Nutr. 2003;22:502\u201310.","journal-title":"J Am Coll Nutr"},{"key":"672_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41598-017-18558-6","volume":"8","author":"L-H Chang","year":"2018","unstructured":"Chang L-H, Lin H-C, Huang S-S, Chen I-C, Chu K-W, Chih C-L, et al. Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation. Sci Rep. 2018;8:118. \n                    https:\/\/doi.org\/10.1038\/s41598-017-18558-6\n                    \n                  .","journal-title":"Sci Rep"},{"key":"672_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.prostaglandins.2014.09.003","volume":"113\u2013115","author":"JW Nelson","year":"2014","unstructured":"Nelson JW, Young JM, Borkar RN, Woltjer RL, Quinn JF, Silbert LC, et al. Role of soluble epoxide hydrolase in age-related vascular cognitive decline. Prostaglandins Other Lipid Mediat. 2014;113\u2013115:30\u20137. \n                    https:\/\/doi.org\/10.1016\/j.prostaglandins.2014.09.003\n                    \n                  .","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"672_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. Am J Roentgenol. 1987;149:351\u20136. \n                    https:\/\/doi.org\/10.2214\/ajr.149.2.351\n                    \n                  .","journal-title":"Am J Roentgenol"},{"key":"672_CR18","doi-asserted-by":"publisher","first-page":"40676","DOI":"10.1074\/jbc.M507787200","volume":"280","author":"H Obinata","year":"2005","unstructured":"Obinata H, Hattori T, Nakane S, Tatei K, Izumi T. Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A. J Biol Chem. 2005;280:40676\u201383. \n                    https:\/\/doi.org\/10.1074\/jbc.M507787200\n                    \n                  .","journal-title":"J Biol Chem"},{"key":"672_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.psychres.2017.02.056","volume":"252","author":"M Hennebelle","year":"2017","unstructured":"Hennebelle M, Otoki Y, Yang J, Hammock BD, Levitt AJ, Taha AY, et al. Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression: an exploratory study. Psychiatry Res. 2017;252:94\u2013101. \n                    https:\/\/doi.org\/10.1016\/j.psychres.2017.02.056\n                    \n                  .","journal-title":"Psychiatry Res"},{"key":"672_CR20","doi-asserted-by":"publisher","first-page":"8085","DOI":"10.1021\/ac901282n","volume":"81","author":"J Yang","year":"2009","unstructured":"Yang J, Schmelzer K, Georgi K, Hammock BD. Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Chem. 2009;81:8085\u201393. \n                    https:\/\/doi.org\/10.1021\/ac901282n\n                    \n                  .","journal-title":"Anal Chem"},{"key":"672_CR21","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/jmri.22004","volume":"31","author":"E Gibson","year":"2010","unstructured":"Gibson E, Gao F, Black SE, Lobaugh NJ. Automatic segmentation of white matter hyperintensities in the elderly using FLAIR images at 3T. J Magn Reson Imaging. 2010;31:1311\u201322. \n                    https:\/\/doi.org\/10.1002\/jmri.22004\n                    \n                  .","journal-title":"J Magn Reson Imaging"},{"key":"672_CR22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.neuroimage.2010.09.013","volume":"54","author":"J Ramirez","year":"2011","unstructured":"Ramirez J, Gibson E, Quddus A, Lobaugh NJ, Feinstein A, Levine B, et al. Lesion explorer: a comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue. NeuroImage. 2011;54:963\u201373. \n                    https:\/\/doi.org\/10.1016\/j.neuroimage.2010.09.013\n                    \n                  .","journal-title":"NeuroImage"},{"issue":"1","key":"672_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10548-012-0228-z","volume":"26","author":"J Ramirez","year":"2013","unstructured":"Ramirez J, Scott CJ, Black SE. A short-term scan-rescan reliability test measuring brain tissue and subcortical hyperintensity volumetrics obtained using the lesion explorer structural MRI processing pipeline. Brain Topogr. 2013;26(1):35\u20138. \n                    https:\/\/doi.org\/10.1007\/s10548-012-0228-z\n                    \n                  .","journal-title":"Brain Topogr"},{"key":"672_CR24","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1161\/01.STR.0000237236.88823.47","volume":"37","author":"V Hachinski","year":"2006","unstructured":"Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220\u201341. \n                    https:\/\/doi.org\/10.1161\/01.STR.0000237236.88823.47\n                    \n                  .","journal-title":"Stroke"},{"key":"672_CR25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/FJC.0b013e318185fa3c","volume":"52","author":"A Ulu","year":"2008","unstructured":"Ulu A, Davis BB, Tsai H-J, Kim I-H, Morisseau C, Inceoglu B, et al. Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model. J Cardiovasc Pharmacol. 2008;52:314\u201323. \n                    https:\/\/doi.org\/10.1097\/FJC.0b013e318185fa3c\n                    \n                  .","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9","key":"672_CR26","doi-asserted-by":"publisher","first-page":"e0162147","DOI":"10.1371\/journal.pone.0162147","volume":"11","author":"A Hanif","year":"2016","unstructured":"Hanif A, Edin ML, Zeldin DC, Morisseau C, Nayeem MA. Effect of soluble epoxide hydrolase on the modulation of coronary reactive hyperemia: role of oxylipins and PPAR\u03b3. PLoS One. 2016;11(9):e0162147. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0162147\n                    \n                  .","journal-title":"PLoS One"},{"key":"672_CR27","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3758\/BF03206553","volume":"36","author":"KJ Preacher","year":"2004","unstructured":"Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput. 2004;36:717\u201331.","journal-title":"Behav Res Methods Instrum Comput"},{"key":"672_CR28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1369\/jhc.2008.950659","volume":"56","author":"P Sura","year":"2008","unstructured":"Sura P, Sura R, Enayetallah AE, Grant DF. Distribution and expression of soluble epoxide hydrolase in human brain. J Histochem Cytochem. 2008;56:551\u20139. \n                    https:\/\/doi.org\/10.1369\/jhc.2008.950659\n                    \n                  .","journal-title":"J Histochem Cytochem"},{"key":"672_CR29","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.1038\/s41598-017-02914-7","volume":"7","author":"M Hennebelle","year":"2017","unstructured":"Hennebelle M, Zhang Z, Metherel AH, Kitson AP, Otoki Y, Richardson CE, et al. Linoleic acid participates in the response to ischemic brain injury through oxidized metabolites that regulate neurotransmission. Sci Rep. 2017;7:4342. \n                    https:\/\/doi.org\/10.1038\/s41598-017-02914-7\n                    \n                  .","journal-title":"Sci Rep"},{"key":"672_CR30","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jagp.2014.09.008","volume":"23","author":"C Santiago","year":"2015","unstructured":"Santiago C, Herrmann N, Swardfager W, Saleem M, Oh PI, Black SE, et al. White matter microstructural integrity is associated with executive function and processing speed in older adults with coronary artery disease. Am J Geriatr Psychiatry. 2015;23:754\u201363. \n                    https:\/\/doi.org\/10.1016\/j.jagp.2014.09.008\n                    \n                  .","journal-title":"Am J Geriatr Psychiatry"},{"key":"672_CR31","doi-asserted-by":"publisher","first-page":"e673","DOI":"10.1212\/WNL.0000000000004983","volume":"90","author":"W Swardfager","year":"2018","unstructured":"Swardfager W, Cogo-Moreira H, Masellis M, Ramirez J, Herrmann N, Edwards JD, et al. The effect of white matter hyperintensities on verbal memory. Neurology. 2018;90:e673\u2013e82. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004983\n                    \n                  .","journal-title":"Neurology"},{"key":"672_CR32","doi-asserted-by":"publisher","first-page":"P1515","DOI":"10.1016\/j.jalz.2017.07.636","volume":"13","author":"L Shinto","year":"2017","unstructured":"Shinto L, Lahna D, Murchison CF, Dodge H, Hagen K, Quinn JF, et al. Plasma Omega-6 derived metabolite is associated with an \u201cunfavorable\u201d MRI profile and an Omega-3 derived metabolite is associated with a \u201cfavorable\u201d MRI profile in a cohort of cognitively Normal hypertensive young-old. Alzheimers Dement. 2017;13:P1515\u2013P6. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2017.07.636\n                    \n                  .","journal-title":"Alzheimers Dement"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-018-0672-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12975-018-0672-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-018-0672-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T20:16:12Z","timestamp":1573762572000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12975-018-0672-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["672"],"URL":"https:\/\/doi.org\/10.1007\/s12975-018-0672-5","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]},"assertion":[{"value":"23 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"DY declares that she has no conflict of interest.HCM declares that he has no conflict of interest.RHS declares grant and personnel funding from the Heart and Stroke Foundation, CIHR, Ontario Brain Institute, Sunnybrook Health Sciences Centre and the University of Toronto, Department of Medicine.NH declares research support from Lundbeck and consultant fees from Astellas, Merck & Lilly.PCC declares that he has no conflict of interest.JP declares that she has no conflict of interest.DTS declares that he has no conflict of interest. .SEB declares institutional grants from Pfizer, GE Healthcare, Eli Lilly, Cognoptix, Biogen Idec, and personal honoraria from Novartis, Merck, Pfizer, Eli Lilly, and Medscape\/Biogen.AT declares that he has no conflict of interest.WS declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}